AOA DX, Inc

The Global Alliance for TB Drug Development Inc., based in New York, is a pioneering organization dedicated to the research and development of new and effective treatments for tuberculosis (TB). With a mission to transform TB therapy, the Alliance manages the largest pipeline of new TB drugs in history, aiming to make innovative treatments accessible to all who need them. Celebrating 25 years of commitment to eradicating TB, the organization focuses on developing faster, simpler, and more effective cures for the disease, particularly drug-resistant forms of TB. Through collaborations and initiatives like the multi-manufacturer strategy, the Alliance works tirelessly to ensure that advancements in TB treatment are available globally, reinforcing the idea that access to treatment is a fundamental human right. Generated from the website

Tactical Therapeutics is a specialized healthcare provider located in New York, NY, focused on delivering innovative therapeutic solutions. Their services are designed to cater to the unique needs of each patient, ensuring a personalized approach to treatment. With a dedication to improving the quality of life for individuals, Tactical Therapeutics employs evidence-based practices and advanced techniques. Their commitment to excellence in patient care sets them apart in the competitive healthcare landscape. Generated from the website

Envisagenics Inc, based in New York, NY, is a pioneering biotechnology company that leverages its AI platform, SpliceCore, to enhance the discovery and therapeutic targeting of RNA splicing. By integrating deep expertise in RNA biology with advanced AI, the company aims to identify novel therapeutic targets in oncology and neurodegeneration that are often overlooked by conventional methods. Dedicated to delivering transformative treatments, Envisagenics fosters a collaborative, patient-driven environment that prioritizes impactful healthcare solutions. The company's innovative approach harnesses the potential of RNA splicing to unlock breakthrough treatments for patients in need. Generated from the website